Also, TCGA material showed a large variance in NFE2L3 expression levels in both primary and metastatic melanoma with overlapping quartiles, and therefore, a large set of samples would be needed to recognize a significant trend. The gene discussed is NFE2L3; the disease is metastatic melanoma.